-
If you purchased shares of Aegerion Pharmaceuticals Inc (NASDAQ: AEGR), you might have certain options and should contact the Shareholders Foundation, Inc.
-
To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.
Lawsuit Overview
November 30, 2017 - The court approved the settlement and entered the orders approving the plan of allocation, the motion for attorneys’ fees and expenses, and dismissing the action with prejudice. June 29, 2017 - The court preliminarily approved the settlement. January 17, 2017 - Parties filed a stipulation of settlement. August 21, 2015 - The lead plaintiff filed a second amended...
You must register (for free) or login to view the entire case.
